TipRanks
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market
DXRX
Diaceutics
RESEARCH TOOLSreports
Want to see GB:DXRX full AI Analyst Report?

Diaceutics (DXRX) Ratios

13 Followers

Diaceutics Ratios

GB:DXRX's free cash flow for Q2 2026 was £0.67. For the 2026 fiscal year, GB:DXRX's free cash flow was decreased by £ and operating cash flow was £-0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.55 3.43 3.80 6.40 8.23
Quick Ratio
 2.55 3.43 3.80 6.40 8.23
Cash Ratio
 0.70 0.86 1.64 3.80 5.29
Solvency Ratio
 0.46 0.62 0.33 0.54 0.65
Operating Cash Flow Ratio
 0.36 0.17 0.08 0.30 1.37
Short-Term Operating Cash Flow Coverage
 14.92 0.00 0.00 0.00 41.52
Net Current Asset Value
£ 16.00M£ 19.83M£ 20.77M£ 22.48M£ 25.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.02 0.02 0.03 0.03
Debt-to-Equity Ratio
 0.05 0.03 0.03 0.03 0.03
Debt-to-Capital Ratio
 0.05 0.03 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.35 1.24 1.22 1.14 1.14
Debt Service Coverage Ratio
 17.73 102.33 55.15 46.23 15.32
Interest Coverage Ratio
 -17.16 4.59 -45.46 -45.73 4.71
Debt to Market Cap
 <0.01 0.00 0.00 0.00 <0.01
Interest Debt Per Share
 0.03 0.01 0.01 0.02 0.02
Net Debt to EBITDA
 -1.09 -1.02 -4.21 -6.55 -5.13
Profitability Margins
Gross Profit Margin
67.81%67.97%87.91%83.15%71.97%
EBIT Margin
-2.28%0.69%-5.77%-10.19%3.08%
EBITDA Margin
13.37%15.81%8.62%9.95%18.50%
Operating Profit Margin
-2.28%0.69%-7.63%-12.73%2.95%
Pretax Profit Margin
-1.48%0.62%-5.93%-10.29%2.89%
Net Profit Margin
-0.66%0.25%-5.30%-7.37%3.71%
Continuous Operations Profit Margin
-0.66%0.25%-5.30%-7.37%3.71%
Net Income Per EBT
44.21%40.42%89.26%71.62%128.37%
EBT Per EBIT
64.94%90.23%77.72%80.78%98.09%
Return on Assets (ROA)
-0.52%0.19%-3.50%-3.77%1.50%
Return on Equity (ROE)
-0.68%0.24%-4.27%-4.28%1.70%
Return on Capital Employed (ROCE)
-2.32%0.64%-6.01%-7.19%1.29%
Return on Invested Capital (ROIC)
-1.02%0.26%-5.34%-5.13%1.28%
Return on Tangible Assets
-0.74%0.29%-5.13%-5.62%2.19%
Earnings Yield
-0.17%0.09%-1.61%-2.38%1.14%
Efficiency Ratios
Receivables Turnover
 2.21 1.83 2.15 2.34 1.87
Payables Turnover
 3.22 8.01 3.19 3.75 7.20
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 16.40 23.10 19.16 12.48 9.32
Asset Turnover
 0.79 0.77 0.66 0.51 0.40
Working Capital Turnover Ratio
 2.14 1.81 1.42 0.93 0.71
Cash Conversion Cycle
 51.62 153.56 55.56 58.60 144.46
Days of Sales Outstanding
 165.05 199.12 169.81 155.96 195.13
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 113.44 45.56 114.25 97.35 50.67
Operating Cycle
 165.05 199.12 169.81 155.96 195.13
Cash Flow Ratios
Operating Cash Flow Per Share
 0.05 0.02 <0.01 0.02 0.06
Free Cash Flow Per Share
 0.05 0.02 -0.05 -0.04 <0.01
CapEx Per Share
 <0.01 <0.01 0.05 0.06 0.06
Free Cash Flow to Operating Cash Flow
 0.99 0.95 -6.12 -2.70 0.05
Dividend Paid and CapEx Coverage Ratio
 111.32 21.07 0.14 0.27 1.06
Capital Expenditure Coverage Ratio
 111.32 21.07 0.14 0.27 1.06
Operating Cash Flow Coverage Ratio
 1.97 1.30 0.61 1.09 3.87
Operating Cash Flow to Sales Ratio
 0.10 0.04 0.02 0.06 0.26
Free Cash Flow Yield
2.50%1.32%-3.76%-4.84%0.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -603.12 1.16K -62.24 -41.97 87.75
Price-to-Sales (P/S) Ratio
 3.95 2.82 3.30 3.09 3.26
Price-to-Book (P/B) Ratio
 4.22 2.67 2.66 1.80 1.49
Price-to-Free Cash Flow (P/FCF) Ratio
 40.01 75.98 -26.62 -20.68 228.54
Price-to-Operating Cash Flow Ratio
 39.68 72.37 162.81 55.89 12.34
Price-to-Earnings Growth (PEG) Ratio
 0.86 -11.04 25.77 0.12 3.09
Enterprise Value Multiple
 28.48 16.79 34.01 24.51 12.48
Enterprise Value
 157.33M 102.07M 94.31M 57.82M 45.02M
EV to EBITDA
 28.48 16.79 34.01 24.51 12.48
EV to Sales
 3.81 2.66 2.93 2.44 2.31
EV to Free Cash Flow
 38.54 71.63 -23.69 -16.31 161.95
EV to Operating Cash Flow
 38.20 68.23 144.86 44.10 8.75
Tangible Book Value Per Share
 0.27 0.29 0.29 0.30 0.32
Shareholders’ Equity Per Share
 0.46 0.48 0.47 0.48 0.51
Tax and Other Ratios
Effective Tax Rate
 0.56 0.60 0.11 0.28 -0.28
Revenue Per Share
 0.49 0.45 0.38 0.28 0.23
Net Income Per Share
 >-0.01 <0.01 -0.02 -0.02 <0.01
Tax Burden
 0.44 0.40 0.89 0.72 1.28
Interest Burden
 0.65 0.90 1.03 1.01 0.94
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.70 0.82 0.96 0.96 0.83
Stock-Based Compensation to Revenue
 0.00 0.02 0.03 0.02 0.03
Income Quality
 -15.20 15.42 -0.34 -0.75 7.11
Currency in GBP